Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Australia Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20043
20062
20071
20084
20093
20102
20113
20122
20133
20142
20152
20163
20172
20182
20194
20202
20218
20223
20235
20243
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Terminated16
Recruiting8
Active, not recruiting3
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion12
United Therapeutics11
Merck Sharp & Dohme LLC5
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA4
Gilead Sciences3
Novartis Pharmaceuticals3
Aerovate Therapeutics2
Aires Pharmaceuticals, Inc.2
Bayer2
Biogen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension67
Hypertension, Pulmonary22
Familial Primary Pulmonary Hypertension5
Cardiovascular Diseases4
Hypertension4
Lung Diseases4
Respiratory Tract Diseases4
Vascular Diseases4
Connective Tissue Diseases2
Hereditary Sensory and Autonomic Neuropathies1

Trials

Showing 26 to 50 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.